Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women: a randomised controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0711
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intravenous ferric derisomaltose versus oral iron for persistent iron deficient pregnant women: a randomised controlled trial ; day:15 ; month:9 ; year:2022 ; pages:1-9
Archives of gynecology and obstetrics ; (15.9.2022), 1-9
- Creator
-
Hansen, Rebecka
Sommer, Veronika Markova
Pinborg, Anja
Krebs, Lone
Thomsen, Lars Lykke
Moos, Torben
Holm, Charlotte
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00404-022-06768-x
- URN
-
urn:nbn:de:101:1-2022120221254598196881
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hansen, Rebecka
- Sommer, Veronika Markova
- Pinborg, Anja
- Krebs, Lone
- Thomsen, Lars Lykke
- Moos, Torben
- Holm, Charlotte
- SpringerLink (Online service)
Other Objects (12)
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment
Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty
Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review
Ferrous iron content of intravenous iron formulations
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
Factors affecting the determination of iron species in the presence of ferric iron
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Ferric carboxymaltose : Ferinject - mastering the art of iron therapy
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment
Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty
Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review
Ferrous iron content of intravenous iron formulations
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
Factors affecting the determination of iron species in the presence of ferric iron
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Ferric carboxymaltose : Ferinject - mastering the art of iron therapy
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment
Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty
Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review
Ferrous iron content of intravenous iron formulations
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
Factors affecting the determination of iron species in the presence of ferric iron
FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Ferric carboxymaltose : Ferinject - mastering the art of iron therapy